Analysis of the efficacy of EEG after maprotiline administration
Libiger, J.; Hanus, H.; Kindernayová, H.; Valach, M.; Zapletálek, M.
Activitas Nervosa Superior 24(2): 106-111
1982
ISSN/ISBN: 0001-7604 PMID: 7102222 Document Number: 183057
Document emailed within 1 workday
Related Documents
Stepanek, J. 1975: Cardiopulmonary effects after I.v. administration of maprotiline in the dog Archives Internationales de Pharmacodynamie et de Therapie 213(2): 338-350Rouillon, F.; Serrurier, D.; Miller, H.D.; Gerard, M.J. 1991: Prophylactic efficacy of maprotiline on unipolar depression relapse Journal of Clinical Psychiatry 52(10): 423-431
Montgomery, S.A.; Mcauley, R.; Montgomery, D.B.; Dawling, S.; Braithwaite, R.A. 1980: Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial Clinical Therapeutics 3(4): 292-310
Gaponova, N.I.; Abdrakhmanov, V.R.; Baratashvili, V.L.; Tereshchenko, S.N. 2011: Analysis of efficacy and safety of administration of moxonidine in patients with arterial hypertension and hypertensive crises Kardiologiia 51(6): 91-96
Lindsay, P.G.; Olsen, R.B. 1985: Maprotiline in pain-depression Journal of Clinical Psychiatry 46(6): 226-228
Wettengel, R. 1985: Maprotiline in asthma therapy Deutsche Medizinische Wochenschrift 110(12): 480-481
Bilikiewicz, A.; Landowski, J. 1976: Evaluation of the antidepressive action of maprotiline Psychiatria Polska 10(4): 367-374
Molcan, J.; Novotný, V.; Nábĕlek, L. 1982: Treatment of involutional depression with maprotiline Activitas Nervosa Superior 24(2): 77-80
Uchino, M.; Araki, S.; Yoshida, O.; Uekawa, K.; Nagata, J. 1983: Efficacy of alternate-day corticosteroid administration in the treatment of polymyositis Rinsho Shinkeigaku 23(10): 842-846
Trave, F.; Canobbio, L.; Au, J.L.; Rustum, Y.M. 1987: Role of administration route in the therapeutic efficacy of doxifluridine Journal of the National Cancer Institute 78(3): 527-532
North, D.S.; Retzinger, T.; Thompson, J.D. 1983: Seizures and delirium associated with overdosage of maprotiline hydrochloride Clinical Pharmacy 2(4): 370-373
Jean, P.; Rodor, F.; Jean-Pastor, M.J.; Hayek-Lanthois, M.; Jouglard, J. 1985: Hepatitis following acute intoxication with maprotiline (Ludiomil) Journal de Toxicologie Clinique et Experimentale 5(2): 121-123
Meng, J.; Shao, B.; Wu, G.; Xue, Y. 2004: Determination of amitriptyline and maprotiline in health foods by GC-MS Se Pu 22(3): 292
Magureanu, I.; Schmitt, G.; Joachim, H. 1992: Suicide with chloroquine combined with maprotiline and trimipramine Archiv für Kriminologie 190(3-4): 82-87
Pirozynski, T.; Chiriţă, V.; Mungiu, O.C.; Cosmovici, N.; Boişteanu, P. 1987: Clinical considerations regarding the use of maprotiline in psychiatric treatment Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 91(2): 251-255
Zukervar, P.; Vial, T.; Jay, P.; Delcombel, M.; Descotes, J. 1990: The Stevens-Johnson syndrome from maprotiline and propranolol? Journal de Toxicologie Clinique et Experimentale 10(3): 169-172
Ogilvie, G.K.; Moore, A.S.; Obradovich, J.E.; Elmslie, R.E.; Vail, D.M.; Straw, R.C.; Salmon, M.D.; Klein, M.K.; Atwater, S.W.; Ciekot, P.E. 1993: Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors Journal of the American Veterinary Medical Association 202(11): 1839-1844
Lavrentieva, A.; Kontakiotis, T.; Bitzani, M.; Parlapani, A.; Thomareis, O.; Scourtis, H.; Tsotsolis, N.; Lazaridis, L.; Giala, M.-A. 2008: The efficacy of antithrombin administration in the acute phase of burn injury Thrombosis and Haemostasis 100(2): 286-290
Cebrelli, T.; Monico, R.; Interdonato, P.F.; Festi, L.; Dominioni, L. 1988: Evaluation of the efficacy of enteral nutrition carried out through various routes of administration Minerva Dietologica E Gastroenterologica 34(4): 229-234
Zherdev, V.P.; Voronina, T.A.; Garibova, T.L.; Kolyvanov, G.B.; Litvin, A.A.; Sariev, A.K.; Tokhmakhchi, V.N.; Vasil'ev, A.E. 2003: Pharmacokinetics and efficacy of phenazepam after transdermal and enteral administration in rats Eksperimental'naia i Klinicheskaia Farmakologiia 66(1): 50-53